# Sienna and Sentimag in Sentinel Lymph Node Biopsy

> **NCT03036475** · NA · UNKNOWN · sponsor: **Yolanda Chan** · enrollment: 52 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Sienna+ injection

## Key facts

- **NCT ID:** NCT03036475
- **Lead sponsor:** Yolanda Chan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036475, "Sienna and Sentimag in Sentinel Lymph Node Biopsy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03036475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*